NovImmune
Series D+NovImmune raised €49M in a Series D+ round in Feb 2014. The company is based in Plan-les-Ouates, Switzerland. Investors in the round: Rosetta Capital. Data as of Nov 2026.
Amount raised
€49M
€48,831,015
Native amount
66,000,000 USD
Stage
Series D+
series e
Investors
1
Provenance & confidence
UnverifiedAmount
66,000,000 USD
ECB-at-date → €49M · rate 1.3516 on 2014-01-31
High confidence
Source
No source on record — unverified.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.